KELLI JACOB: Open Payments
NPI 1679809933 · BOSSIER CITY, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,646 in 174 payments from 25 companies in 2025. Trend: 2023 $2,259 · 2024 $3,233 · 2025 $3,646
Food & beverage: $3,205Education: $441
| Company | Payments | Amount |
|---|---|---|
| Calliditas Therapeutics US Inc. | 10 | $372 |
| AstraZeneca Pharmaceuticals LP | 13 | $348 |
| OPKO Pharmaceuticals, LLC | 22 | $341 |
| Fresenius USA Marketing, Inc. | 17 | $318 |
| Novartis Pharmaceuticals Corporation | 15 | $285 |
| Mallinckrodt Hospital Products Inc. | 15 | $273 |
| Travere Therapeutics, Inc. | 8 | $270 |
| Amgen Inc. | 17 | $264 |
| Otsuka America Pharmaceutical, Inc. | 11 | $256 |
| Bayer Healthcare Pharmaceuticals Inc. | 9 | $144 |
Products named: TARPEYO, RAYALDEE, VELPHORO, Fabhalta, ACTHAR, JYNARQUE, FARXIGA, TAVNEOS.
Industry payments across LA — which companies pay providers there.
